Para-aortic lymph node metastasis in relation to serum CA 125 levels and nuclear grade in endometrial carcinoma

Acta Obstetricia et Gynecologica Scandinavica

Volumn 81, Issue 5, 2002, Pages 458-

  Ebina, Yasuhiko ^a   Sakuragi, Noriaki ^a   Hareyama, Hitoshi ^a   Todo, Yukiharu ^a   Nomura, Eij ^a   Takeda, Mahito ^a   Okamoto, Kazuhira ^a   Tamada, Hideto ^a   Yamamoto, Ritsu ^a   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Endometrial carcinoma; Nuclear grade; Para aortic lymph node metastasis; Serum CA 125

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARAAORTIC LYMPH NODE; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

EID: 0036097398     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2002.810514.x     Document Type: Article

References (32)

1. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma
2. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy
3. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study
4. Endometrial carcinoma: Treatment of positive paraaortic nodes
5. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
6. CA 125: A useful marker in endometrial carcinoma
7. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma
8. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma
9. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome
10. Preoperative CA 125 in endometrial cancer. Is it useful?
11. Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values
12. Prospective evaluation of serum CA 125 levels in a normal population, phase I. The specificities of single and serial determinations in testing for ovarian cancer
13. An evaluation of CA125 levels in 291 normal postmenopausal and 20 endometrial adenocarcinoma-bearing women before and after surgery
14. Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma
15. The use of CA-125 in the diagnosis and management of endometriosis
16. The effect of the menstrual cycle on serum CA 125 levels: A population study
17. Comparison of seven immunoassays for the quantification of CA 125 antigen in serum
18. Endometrial carcinoma
19. Diagnostic efficacy of the preoperative lymphoscintigraphy, Ga-67 scintigraphy and computed tomography for detection of lymph node metastasis in cases with ovarian or endometrial carcinoma
20. Computed tomography in endometrial carcinoma
21. Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer
22. CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma
23. CA 125 and CA 19-9 immunolocalization in normal, hyperplastic, and carcinomatous endometrium
24. Multiple serum markers in patients with endometrial cancer
25. A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma
26. Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma
27. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma
28. Serum CA 125 levels and sonography in the pre-operative assessment of myometrial invasion of endometrial cancer
29. Magnetic resonance imaging (MRT) in endometrial carcinoma; preoperative estimation of depth of myometrial invasion
30. Radiologic staging in patients with endometrial cancer: A meta-analysis
31. Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging
32. Carcinoma of the endometrium III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma